gyki 53655 has been researched along with Epilepsy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Ari, Y; Dzhala, V; Khalilov, I; Khazipov, R; Lamsa, K; Leinekugel, X; Medina, I; Melyan, Z | 1 |
| Gacsályi, I; Gigler, G; Gyertyán, I; Lévay, G; Szabados, T | 1 |
2 other study(ies) available for gyki 53655 and Epilepsy
| Article | Year |
|---|---|
Maturation of kainate-induced epileptiform activities in interconnected intact neonatal limbic structures in vitro.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Benzodiazepines; Calcium; Electrophysiology; Entorhinal Cortex; Epilepsy; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hippocampus; Kainic Acid; Limbic System; Male; Organ Culture Techniques; Potassium; Rats; Rats, Wistar; Septal Nuclei; Synapses; Tetrodotoxin | 1999 |
Duration of action of GYKI 52466 and its analogues in antiepileptic, anti-ischaemic and muscle relaxant tests.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Mice; Muscle Relaxants, Central | 1999 |